or
forgot password
  • cancer clinical trials in wichita, KS

  • S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Associates in Womens Health, PA - North Review

    Trial Locations
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Cancer Center of Kansas, P.A.

    Trial Locations
    Cancer Center of Kansas, P.A.
    Associates in Womens Health
    Cancer Center of Kansas, P.A. - Wichita
    Kidney Cancer
    Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Leukemia
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Wichita CCOP

    Trial Locations
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Creatine in Treating Patients With Cancer-Associated Weight Loss
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Leukemia
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Prostate Cancer
    Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, P.A. - Wichita
    Cancer Center of Kansas, P.A. - Medical Arts Tower
    Associates in Womens Health, P.A. - North Review
    Breast Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Wichita CCOP

    Trial Locations
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Associates in Womens Health

    Trial Locations
    Associates in Womens Health
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Colorectal Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Wichita CCOP

    Trial Locations
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer